A detailed history of Engineers Gate Manager LP transactions in Genmab A/S stock. As of the latest transaction made, Engineers Gate Manager LP holds 16,157 shares of GMAB stock, worth $330,733. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,157
Previous 17,015 5.04%
Holding current value
$330,733
Previous $427,000 7.96%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.84 - $28.48 $20,454 - $24,435
-858 Reduced 5.04%
16,157 $393,000
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $427,586 - $515,044
17,015 New
17,015 $427,000
Q4 2023

Feb 14, 2024

BUY
$27.94 - $35.44 $761,644 - $966,094
27,260 New
27,260 $867,000
Q2 2023

Aug 14, 2023

BUY
$37.4 - $42.94 $434,475 - $498,833
11,617 New
11,617 $441,000
Q4 2022

Feb 14, 2023

BUY
$33.8 - $47.06 $571,017 - $795,031
16,894 New
16,894 $715,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.